BioLargo Announces CupriDyne Clean
SANTA ANA, CA – (May 2, 2016) – BioLargo, Inc. (OTCQB: BLGO) today announced the availability of “CupriDyne Clean” All-Purpose Free Iodine Wash and Industrial Odor Eliminators for unsurpassed odor...
View ArticleBioLargo Concludes Successful Customer Trials and New Sales for CupriDyne...
SANTA ANA, CA – (May 11, 2016) – BioLargo, Inc. (OTCQB: BLGO) announced today that it had successfully concluded a series of free trials with industry leading corporations and municipalities to...
View ArticleBioLargo to Present at the Rodman & Renshaw 18th Annual Global Investment...
– BioLargo President Dennis Calvert to Present at 4:15 p.m. ET on September 12th – WESTMINSTER, CA—(September 9, 2016) – BioLargo, Inc. (OTCQB: BLGO) will present at the Rodman & Renshaw 18th...
View ArticleBioLargo closes private offering and improves balance sheet on its march to...
WESTMINSTER, CA—(September 19, 2016) – BioLargo, Inc. (OTCQB: BLGO) announced it had closed its 2015 Unit Offering to further investments. The company also reported that with the closing of this...
View ArticleBiolargo Engages CB&I to Support Advanced Technology
WESTMINSTER, CA— (December 1, 2016) – BioLargo, Inc. (OTCQB: BLGO) announced that its subsidiary BioLargo Maritime Solutions, Inc. has developed and created Advanced Oxidation System technology (AOS),...
View ArticleBiolargo Signs Veteran Water Industry Executive Mark Lambert as Strategic...
WESTMINSTER, CA— (February 7, 2017) – BioLargo, Inc. (OTCQB: BLGO) announced that Mark Lambert had joined its team as a “strategic advisor” to help develop and refine the company’s commercialization...
View ArticleBioLargo Expands Research Expertise to Scale-Up and Enhance AOS Technology...
SANTA ANA, CA – August 3, 2015 – BioLargo, Inc. (OTCQB: BLGO) announced today that it has hired three talented researchers to scale-up and enhance its current AOS technology. Dr. Ahmed Moustafa, Dr....
View ArticleBioLargo gains momentum with capital infusion and expanding grants, adding...
Dear Shareholder, It is with great pleasure I write to share a few highlights of our recent advancements and the upcoming opportunities for BioLargo. The future for BioLargo is very bright and we find...
View ArticleClik here to view.
BioLargo Secures Financing for Its Advanced Wound Care Products Targeting FDA...
SANTA ANA, CA–(Marketwired – Jan 6, 2016) – BioLargo, Inc. (OTCQB: BLGO) subsidiary Clyra Medical Technologies, Inc. has successfully concluded a financing from Sanatio Capital LLC for $750,000 in...
View ArticleBIOLARGO’S ODOR-NO-MORE PRODUCTS APPROVED TO SELL THROUGH GSA ADVANTAGE AND...
BioLargo, Inc. (OTCQB: BLGO) announced today that two product lines (consisting of 9 SKUs) of its Nature’s Best Science products were awarded a five year U.S. General Services Administration (GSA)...
View Article
